Evaluation of gene editing in CHO cells using the Cas‐ CLOVER system
Biotechnology Progress · 2026
DOI: 10.1002/btpr.70108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2026. Verfasst von Tiffany McLamarrah und 13 weiteren Autor:innen. Beteiligte Einrichtung: Mammalian Platform, Global CMC Development, Framingham, Massachusetts, USA. Hauptthemen laut MEDLINE: Glutamate-Ammonia Ligase, Gene Editing, CRISPR-Cas Systems. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Recent advances in gene editing technologies have transformed the genetic engineering of Chinese hamster ovary (CHO) hosts, enabling the development of cell lines with improved stability and productivity. In this study, we employed the programmable nuclease (PN) Cas‐CLOVER to precisely target the Glutamine synthetase (GS) locus in CHO cells. A total of 30 unique serum‐free, suspension‐adapted CHO‐K1 candidate host cell lines were subjected to Cas‐CLOVER‐mediated gene editing, generating over one hundred potential GS knockout (GSKO) clones. A subset of the GSKO clones was subsequently validated using three orthogonal methods to confirm complete knockout of the GS gene in 98 clones. Randomly selected GSKO clones were utilized to produce standard monoclonal antibodies. The resulting pools demonstrated enhanced productivity, with up to a 14.5‐fold increase in titer compared to their wild‐type parental hosts. These findings highlight the potential of gene editing approaches to significantly improve recombinant protein production in CHO expression systems, offering valuable insights for biopharmaceutical manufacturing applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mammalian Platform, Global CMC Development, Framingham, Massachusetts, USA.
- Sanofi Satellite Lab, iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
- bPrescient, San Diego, California, USA.
- Cell Line Editing Department, Demeetra AgBio, Lexington, Kentucky, USA.
ORCID-Profile: Tiffany McLamarrah
Zitieren
APA
McLamarrah, T., Aral, E., Hoffman, M., Tedstone, J., King, T., Vitko, J., Sebastião, M. J., Escandell, J. M., Dias, M. M., McCall, I., Machado, D., Cairns, V., DeMaria, C., & Scarcelli, J. J. (2026). Evaluation of gene editing in CHO cells using the Cas‐ CLOVER system. Biotechnology Progress. https://doi.org/10.1002/btpr.70108
Vancouver
McLamarrah T, Aral E, Hoffman M, Tedstone J, King T, Vitko J, et al. Evaluation of gene editing in CHO cells using the Cas‐ CLOVER system. Biotechnology Progress. 2026. doi:10.1002/btpr.70108
BibTeX
@article{McLamarrah2026,
author = {McLamarrah, Tiffany and Aral, Efecan and Hoffman, Michael and Tedstone, Jennifer and King, Thomas and Vitko, Jason and Sebastião, Maria João and Escandell, Jose M and Dias, Mafalda M and McCall, Iona and Machado, Daniel and Cairns, Victor and DeMaria, Christine and Scarcelli, John J},
title = {Evaluation of gene editing in CHO cells using the Cas‐ CLOVER system},
journal = {Biotechnology Progress},
year = {2026},
doi = {10.1002/btpr.70108}
}
EUVIMED